Life Sciences & Research
AI and compliant data infrastructure for medical research
Research-ready data and models across institutions and borders, with de-identification and GDPR-compliant data flows designed in from the first pipeline.
The problem
The data for your next study already exists, spread across sites and countries in formats that don’t match, and identifiable records can’t simply be copied around.
- 01
Data that is hard to share
Identifiable records can't move freely between sites, sponsors and countries, so studies stall at data access.
- 02
Inconsistent definitions
Each source codes diagnoses, procedures and outcomes differently, which undermines cohort and outcome definitions.
- 03
Documentation burden
Literature review, protocol drafting and eligibility screening take expert time away from the research itself.
Infographic: three sites code type 2 diabetes differently; each record is de-identified at its origin and mapped to one OMOP concept.
Same diagnosis, three sites, one definition
Identifiers are removed where the data lives. Only the harmonized, de-identified record moves.
How it works
From scattered records to a research-ready cohort
Follow one multi-site study through a pipeline we build with your research team. Data is prepared where it lives, and investigators approve every cohort.
- 01System
Sources are mapped
Each site’s data is inventoried in place: what exists, what it contains and which rules apply to it.
Source inventory
- Sources: 3 sites · 2 countries
- Formats: CSV, X12, FHIR
- Legal basis: documented
Data stays at its originData Science
- 02System
Identifiers are removed
Data is de-identified at the source using HIPAA Safe Harbor or Expert Determination, and EU data is pseudonymized before it moves.
De-identification
- Method: Expert Determination
- Dates: shifted per patient
- EU data: pseudonymized at origin
Method documentedData Science
- 03System
Definitions are harmonized
Sources are mapped to the OMOP common data model, so diagnoses, drugs and outcomes mean the same thing at every site.
OMOP mapping
- Model: OMOP CDM
- Vocabularies: ICD-10, RxNorm, LOINC
- Unmapped codes: flagged for review
Mappings versionedData Science
- 04AI agent
Candidates are screened
Research agents check candidates against the protocol’s eligibility criteria and explain why each one meets or fails them.
Eligibility screen
- Criteria: 12 inclusion · 8 exclusion
- Candidates: ranked with reasons
- Uncertain: sent to coordinator
Reasons attached to every resultAI Solutions
- 05Person
Investigators approve
Investigators and coordinators confirm eligibility and approve the cohort. The agent never enrolls anyone.
Cohort
- Reviewed by: study coordinator
- Cohort: approved
- Changes: logged
Investigator sign-offAI Solutions
- 06System
Results can be reproduced
Analyses run on versioned data with documented transformations, so an auditor or a new analyst can rerun them and get the same result.
Analysis
- Dataset: v1.4, frozen
- Code: versioned
- Results: reproducible
Reproducible by designData Science
What changes
The same work for research teams, without the busywork or the blind spots
Today
- Studies stall waiting for data access
- Each site codes outcomes differently
- Eligibility screened chart by chart
- Identifiable records copied between teams
With UsHealthCloud
- Data prepared where it lives
- One common data model across sites
- Candidates pre-screened with reasons
- Only de-identified or pseudonymized data moves
How we help
Three services, one protected foundation
Data Science
De-identification, OMOP/FHIR harmonization and real-world evidence analytics.
Powers steps1236
Learn moreAI Solutions
Research agents for literature review, cohort screening and protocol drafting.
Powers steps45
Learn moreCybersecurity
Protection for shared research environments and the data moving between them.
Learn more
Where teams start
Start with one workflow, measured against a baseline
Cohort discovery
OMOP · EHR extracts
Trial eligibility screening
Protocols · EHR data
Real-world evidence studies
Claims · registries
Literature review
Abstracts · full texts
Registry curation
Registry exports
Cross-border data sharing
Pseudonymized EU data
Rules that shape the work
Built for the regulations you answer to
HIPAA de-identification
Safe Harbor or Expert Determination decides when health data stops being PHI.
Read the guideGDPR
Health data is special category data, and transfers out of the EU need a documented mechanism.
How we handle itThe Common Rule (45 CFR 46)
Protects human subjects in federally funded research, including review by an institutional review board.
Related reading
- Data ScienceHIPAA de-identification: Safe Harbor vs. Expert DeterminationCompare HIPAA’s two de-identification methods, the 18 Safe Harbor identifiers and when Expert Determination is the better fit for analytics and AI.
- ComplianceThe EU AI Act for healthcare: high-risk AI explainedWhich healthcare AI is high-risk under the EU AI Act, what providers and deployers must do, and the 2027–2028 deadlines set by the Digital Omnibus.
FAQ
Questions we hear from compliance and data teams
Cross-borderCan you support studies with EU participants?
Yes. Pipelines are designed for GDPR-compliant cross-border data flows, with data minimization and de-identification applied before data leaves its origin wherever possible.
StandardsDo you work with the OMOP common data model?
Yes. We harmonize EHR and claims sources to OMOP and FHIR so cohort definitions are consistent across sites.
ModelsCan research agents work on our proprietary literature and protocols?
Yes, within an environment you control, and only with the documents you choose to provide.
Next step
Bring us the study that is stuck at data access.
We'll map the sources, the rules that apply to each, and a path to research-ready data that never copies identifiable records around.
What the first call gives you
- 1A map of your sources and the rules on each
- 2The right de-identification method
- 3A path to one common data model
A short scoping call, then a written proposal. Please don't send patient information.